Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Brett Leav

Dados Biográficos

ID7900185
NOMEBrett Leav
PRENOMESBrett
SOBRENOMELeav
ASSINATURALEAV B
AFILIAÇÕESSeqirus (United Kingdom)
ORCID0000-0003-0907-0817
VERIFICADOSim
TOTAL DE OBRAS3
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR3
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2020
ANO MAIS RECENTE DE PUBLICAÇÃO2024
ÍNDICE H0
  • Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa

    Open Access•Nigel Garrett, Tarylee Reddy et al.•ARTICLE•PLOS Global Public Health•2024

    Limited studies have been conducted on the safety and effectiveness of heterologous COVID-19 vaccine boosting in lower income settings, especially those with high-HIV prevalence., The Sisonke Heterologous mRNA-1273 boost after prime with Ad26.COV2.S (SHERPA) trial evaluated a mRNA-1273 boost after Ad26.COV2.S priming in South Africa. SHERPA was a single-arm, open-label, phase 3 study nested in the Sisonke implementation trial of 500000 healthcare…

  • Efficacy and Safety of the mRNA-1273 Sars-CoV-2 Vaccine

    Open Access•Lindsey R Baden, Hana M El Sahly et al.•ARTICLE•New England Journal of Medicine•2021

    BACKGROUND: Vaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid nanoparticle-encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Covid-19. METHODS: This phase 3 randomized, observer-blinded, placebo-contr…

  • Retrospective Assessment of the Antigenic Similarity of Egg-Propagated and Cell Culture-Propagated Reference Influenza Viruses as Compared with Circulating Viruses across Influenza Seasons 2002–2003 t…

    Open Access•Sankarasubramanian Rajaram, Pirada Suphaphiphat et al.•ARTICLE•International Journal of…•2020

    Suboptimal vaccine effectiveness against seasonal influenza is a significant public health concern, partly explained by antigenic differences between vaccine viruses and viruses circulating in the environment. Haemagglutinin mutations within vaccine viruses acquired during serial passage in eggs have been identified as a source of antigenic variation between vaccine and circulating viruses. This study retrospectively compared the antigenic simila…

Sem obras proeminentes nesta página.

  • Retrospective Assessment of the Antigenic Similarity of Egg-Propagated and Cell Culture-Propagated Reference Influenza Viruses as Compared with Circulating Viruses across Influenza Seasons 2002–2003 t…

    Open Access•Sankarasubramanian Rajaram, Pirada Suphaphiphat et al.•ARTICLE•International Journal of…•2020

    Suboptimal vaccine effectiveness against seasonal influenza is a significant public health concern, partly explained by antigenic differences between vaccine viruses and viruses circulating in the environment. Haemagglutinin mutations within vaccine viruses acquired during serial passage in eggs have been identified as a source of antigenic variation between vaccine and circulating viruses. This study retrospectively compared the antigenic simila…

  • Efficacy and Safety of the mRNA-1273 Sars-CoV-2 Vaccine

    Open Access•Lindsey R Baden, Hana M El Sahly et al.•ARTICLE•New England Journal of Medicine•2021

    BACKGROUND: Vaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid nanoparticle-encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Covid-19. METHODS: This phase 3 randomized, observer-blinded, placebo-contr…

  • Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa

    Open Access•Nigel Garrett, Tarylee Reddy et al.•ARTICLE•PLOS Global Public Health•2024

    Limited studies have been conducted on the safety and effectiveness of heterologous COVID-19 vaccine boosting in lower income settings, especially those with high-HIV prevalence., The Sisonke Heterologous mRNA-1273 boost after prime with Ad26.COV2.S (SHERPA) trial evaluated a mRNA-1273 boost after Ad26.COV2.S priming in South Africa. SHERPA was a single-arm, open-label, phase 3 study nested in the Sisonke implementation trial of 500000 healthcare…

Clinical trial (2 obras) · Immunology (2 obras) · Medicine (2 obras) · SARS-CoV-2 and COVID-19 Research (2 obras) · Adverse effect (1 obras) · Antigen (1 obras) · Antigenic drift (1 obras) · Antigenic shift (1 obras) · Antigenic variation (1 obras) · Aside (1 obras)

Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae